When will Lorazepam Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Lorazepam Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Lorazepam Injection

Brand names: Lorazepam

Category: Neurology

Unavailable 7Limited 3Available 1

FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: May 3, 2018 (in shortage 8 years 4 months) · 4 manufacturers, 11 listed presentations

As of Sep 22, 2026, the FDA lists Lorazepam Injection as currently in shortage. Of 11 manufacturer presentations, 7 Unavailable, 3 Limited, 1 Available.

Ask your pharmacist: which of the 4 manufacturers below can they order right now, and whether a different strength or form of Lorazepam Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) NDC 65219-368-02	Fresenius Kabi USA, LLC	Unavailable	Next release September 2026. Check wholesalers for inventory.
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) NDC 0641-6046-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) NDC 0641-6000-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) NDC 0641-6044-25	Hikma Pharmaceuticals USA, Inc.	Limited	Estimated recovery: TBD
Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) NDC 0641-6001-25	Hikma Pharmaceuticals USA, Inc.	Limited	Estimated recovery: TBD
Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) NDC 76329-8261-1	Amphastar Pharmaceuticals, Inc.	Available	-
Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) NDC 0409-1985-30	Hospira, Inc., a Pfizer Company	Limited	Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027
Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) NDC 0641-6003-25	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) NDC 0641-6045-25	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) NDC 0641-6047-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) NDC 0641-6002-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD

Related medications in shortage

Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Lorazepam Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Lorazepam Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Lorazepam Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/lorazepam-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).